Cayman provides US-based integrated preclinical discovery and development services to the global pharmaceutical, biotechnology, and academic research markets. Our diverse suite of services leverages a team of over 150 highly skilled scientists with expertise in medicinal and computational chemistry, structural biology, complex multi-step organic synthesis, GMP manufacturing, analytical chemistry, biomarker development, immunology, metabolism, cell biology, sample analysis, screening, and custom assay development. We offer a personalized, flexible approach that enables our clients to accelerate their drug discovery and development through a single-source partner, from novel drug design and synthesis to target identification and validation.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
